Confronting ethical dilemmas

• India's GMO gridlock is not a scientific disagreement — it is a governance failure
• Farmers already have awareness, interest, and desire — the formal adoption pathway is the only thing broken
• Unapproved GM seeds are spreading through shadow markets, which proves demand exists
• The state has simultaneously blocked legal access and abandoned enforcement
• Farmers are left bearing all the risk of an unregulated market — that is the core ethical problem

Separating facts from assumptions

• The claim that GM crops harm human health is not supported by WHO or three decades of global evidence
• Environmental risks from gene flow are real but context-dependent — they vary by crop and ecosystem
• Corporate control of seeds is not an inherent feature of GM technology; it depends on IP and competition policy
• Bt cotton showed real early gains — the subsequent distress came from pest resistance and pricing, not the technology itself
• Conflating these distinct questions has allowed misinformation to capture the policy space

Where the real ethical tensions lie

• Farmer autonomy vs. regulatory paternalism — farmers are already choosing GM seeds, just illegally
• Food security vs. environmental precaution — India spends ₹1.6 trillion annually on edible oil imports, and that cost falls on real households
• Scientific approval vs. democratic legitimacy — GEAC cleared Bt brinjal, a minister overrode it, and no transparent framework exists to navigate that tension
• Each dilemma points to a different kind of governance failure
• They cannot be resolved by the same policy instrument

Why good policy has not happened yet

• Regulators face asymmetric incentives — approving a crop that later generates controversy brings political cost, delaying indefinitely brings none
• Organised civil society groups opposing GM are vocal and concentrated; farmers who would benefit are dispersed and politically weak
• The Bt brinjal moratorium in 2010 was not a scientific decision — it was a political one
• The Supreme Court's split verdict on GM mustard reflects the same unresolved tension
• Until the incentive structure facing regulators changes, expect more gridlock regardless of what the science says

What this means for governance priorities

• Farmers need protection from shadow market risks — this is a government failure rooted in the enforcement gap
• Seed market concentration must be addressed separately from biosafety — bundling them has paralysed both debates
• Regulatory credibility needs to be rebuilt through consistent, transparent process — not faster approvals alone
• Policy cannot eliminate residual scientific uncertainty or override deeply held cultural objections
• But it can stop making small farmers bear the cost of decisions made in New Delhi